secwatch / observer

8-K filed December 1, 2025, 6:59 PM ET ticker CYCU CIK 0001868419

other material confidence high sentiment positive materiality 0.45

Cycurion & IQSTEL retain $1M cross-holdings; swap dividends to own shares

Cycurion, Inc.

Each company will distribute $500,000 of its own shares as a one-time pro-rata dividend to its shareholders.
The original $1,000,000 cross-ownership shares are retained intact; the swap is deferred until shares meet seasoning requirements.
Companies signal long-term commitment and joint development in AI, cybersecurity, telecom, and enterprise services.
Joint product updates expected in Q1 and Q2 2026 as new solutions enter the market.

item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001868419-25-000025
form_type: 8-K
ticker: CYCU
cik: 0001868419
company_name: Cycurion, Inc.
filed_at: 2025-12-01T23:59:59+00:00
discovered_at: 2026-05-14T18:02:40.915866+00:00
generated_at: 2026-05-16T15:55:02.808360+00:00
sec_items: ["8.01", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001868419-25-000025
json_url: https://secwatch.observer/filing/0001868419-25-000025.json
markdown_url: https://secwatch.observer/filing/0001868419-25-000025.md
text_url: https://secwatch.observer/filing/0001868419-25-000025.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1868419/000186841925000025/0001868419-25-000025-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1868419/000186841925000025/cycu-20251125.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

NRXP

NRx Pharmaceuticals proposes public offering of common stock; terms not set

NRX Pharmaceuticals, Inc. June 2, 2026, 5:30 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

TOPP

Topppoint issues statement at NYSE request; no undisclosed material developments behind unusual trading

Toppoint Holdings Inc. June 2, 2026, 5:10 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

AVA

Avista signs non-binding MOU for 125 MW load, expandable to 500 MW by 2032

AVISTA CORP June 2, 2026, 5:02 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

ARVN

Arvinas to out-license ARV-806 after completing Phase 1 dose escalation

ARVINAS, INC. June 2, 2026, 4:39 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

JAGX

Jaguar Health issues 64,668 common shares for Series Q Preferred; annual meeting adjourned to June 8

Jaguar Health, Inc. June 2, 2026, 4:10 PM ET other_material Items 1.01, 3.02, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

OTAI

Starlink AI Acquisition closes partial over-allotment, adds $5M to trust

Starlink AI Acquisition Corp June 2, 2026, 4:05 PM ET other_material Items 3.02, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

MLI

Mueller Industries announces 2-for-1 stock split; record date June 25, 2026

MUELLER INDUSTRIES INC June 2, 2026, 10:47 AM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

SLS

SELLAS Life Sciences raised $28.7M from warrant exercises in Apr-May 2026

SELLAS Life Sciences Group, Inc. June 2, 2026, 8:30 AM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001868419-25-000025

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.